Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ALTAREX CORP. (TSE: AXO) -- Ignore unavailable to you. Want to Upgrade?

To: LAURIE SELINE who wrote (266)	12/20/2000 10:11:36 PM
From: DaveAu	Read Replies (1) \| Respond to of 274

Laurie, You were behind me. I had a bid for 5000 at 1.20 and it filled partly yesterday and the rest this morning. I noticed some traders kept jumping in front bidding 1.21 and 1.22. Tax loss selling in Canada ends Friday but the real relief probably comes in early January. This is the cheapest of 15 Canadian bio techs I follow. It could be on the market in 15 months (Q3 filing and accelerated review). The evidence is piling up that the product works well. It doesn't work in everyone but it is easy to determine which patients will benefit. There is no other product approved for the watchful waiting period and very few other products are in clinical trials for ovarian cancer so an accelerated review seems likely. Even a 10 bagger from here would be a low market cap if they can actually get to market. The big problem is they need money and this is a lousy market to raise it in. Dave